Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 16173017)

Published in J Med Virol on November 01, 2005

Authors

Xiaodong Zhang1, Nan Dong, Lihui Yin, Na Cai, Hongtao Ma, Jiacong You, Hang Zhang, Honghui Wang, Ran He, Lihong Ye

Author Affiliations

1: Department of Cancer Research, Institute for Molecular Biology, Tianjin Key Laboratory of Microbial Functional Genomics, College of Life Sciences, Nankai University, Tianjin, P.R. China. zhangxd@nankai.edu.cn

Articles citing this

Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem (2012) 2.16

Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One (2011) 1.44

miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J Biol Chem (2011) 1.11

Chronic hepatitis B in hepatocarcinogenesis. Postgrad Med J (2006) 1.07

Apoptosis in murine norovirus-infected RAW264.7 cells is associated with downregulation of survivin. J Virol (2009) 1.04

A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase. Neoplasia (2010) 1.01

The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells. Carcinogenesis (2013) 1.01

Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Neoplasia (2013) 1.00

Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology (2010) 0.98

p53 gene in treatment of hepatic carcinoma: status quo. World J Gastroenterol (2007) 0.95

Transformation of human liver L-O2 cells mediated by stable HBx transfection. Acta Pharmacol Sin (2009) 0.95

Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition. World J Gastroenterol (2007) 0.92

HBV induced HCC: major risk factors from genetic to molecular level. Biomed Res Int (2013) 0.92

Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP. Mol Cancer (2014) 0.90

Hepatitis B virus X protein promotes hepatoma cell proliferation via upregulation of MEKK2. Acta Pharmacol Sin (2011) 0.86

Anti-hepatitis B virus X protein in sera is one of the markers of development of liver cirrhosis and liver cancer mediated by HBV. J Biomed Biotechnol (2009) 0.86

A mutant of HBx (HBxDelta127) promotes hepatoma cell growth via sterol regulatory element binding protein 1c involving 5-lipoxygenase. Acta Pharmacol Sin (2010) 0.83

Male-specific hepatitis B virus large surface protein variant W4P potentiates tumorigenicity and induces gender disparity. Mol Cancer (2015) 0.82

A mutant of hepatitis B virus X protein (HBx Delta 127) enhances hepatoma cell migration via osteopontin involving 5-lipoxygenase. Acta Pharmacol Sin (2010) 0.82

Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful? World J Gastroenterol (2007) 0.81

Gene expression profiles of human liver cells mediated by hepatitis B virus X protein. Acta Pharmacol Sin (2009) 0.81

Hepatitis B virus X protein up-regulates C4b-binding protein α through activating transcription factor Sp1 in protection of hepatoma cells from complement attack. Oncotarget (2016) 0.77

Interferon-alpha restrains growth and invasive potential of hepatocellular carcinoma induced by hepatitis B virus X protein. World J Gastroenterol (2008) 0.77

Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis. Oncogenesis (2012) 0.77

Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma. Gut Liver (2007) 0.77

Inhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs. PLoS One (2012) 0.76

The Fragment HMGA2-sh-3p20 from HMGA2 mRNA 3'UTR Promotes the Growth of Hepatoma Cells by Upregulating HMGA2. Sci Rep (2017) 0.75

How did hepatitis B virus effect the host genome in the last decade? World J Hepatol (2014) 0.75

Articles by these authors

Controlled ripple texturing of suspended graphene and ultrathin graphite membranes. Nat Nanotechnol (2009) 2.57

A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med (2012) 2.53

Spiral waves in disinhibited mammalian neocortex. J Neurosci (2004) 2.27

Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem (2012) 2.16

Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol Ther (2011) 1.96

Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med (2006) 1.70

Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res (2008) 1.70

Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nat Methods (2012) 1.67

Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome. Crit Care Med (2012) 1.64

Efficacy and safety of mesenchymal stromal cell treatment from related donors for patients with refractory aplastic anemia. Cytotherapy (2013) 1.48

Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One (2011) 1.44

Association between MTR A2756G polymorphism and childhood acute lymphoblastic leukemia: a meta-analysis. Leuk Lymphoma (2013) 1.37

Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology (2012) 1.34

Decision-theoretic models of visual perception and action. Vision Res (2010) 1.31

MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression. Mol Ther (2010) 1.30

Maximum Correntropy Criterion for Robust Face Recognition. IEEE Trans Pattern Anal Mach Intell (2010) 1.30

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. J Clin Invest (2014) 1.29

Preictal and ictal neurovascular and metabolic coupling surrounding a seizure focus. J Neurosci (2011) 1.28

miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma. J Biomed Sci (2011) 1.27

The knowledge-integrated network biomarkers discovery for major adverse cardiac events. J Proteome Res (2008) 1.27

Focal increases in perfusion and decreases in hemoglobin oxygenation precede seizure onset in spontaneous human epilepsy. Epilepsia (2007) 1.26

tRNA-dependent pre-transfer editing by prokaryotic leucyl-tRNA synthetase. J Biol Chem (2009) 1.25

AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder. Cell (2013) 1.25

Graphene-based atomic-scale switches. Nano Lett (2008) 1.21

Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2. Cell Res (2010) 1.19

Spatiotemporal dynamics of perfusion and oximetry during ictal discharges in the rat neocortex. J Neurosci (2009) 1.15

Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells. Transl Res (2007) 1.14

Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition. Biophys J (2013) 1.12

miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J Biol Chem (2011) 1.11

Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers. Clin Sci (Lond) (2013) 1.08

Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer. Cancer Res (2011) 1.08

MCPIP1 down-regulates IL-2 expression through an ARE-independent pathway. PLoS One (2012) 1.06

Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett (2008) 1.05

Spectroscopy of covalently functionalized graphene. Nano Lett (2010) 1.04

Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. Carcinogenesis (2013) 1.04

Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers. PLoS One (2010) 1.04

The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells. J Biol Chem (2012) 1.02

Neurovascular coupling and oximetry during epileptic events. Mol Neurobiol (2006) 1.01

A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase. Neoplasia (2010) 1.01

The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells. Carcinogenesis (2013) 1.01

Improved working memory performance through self-regulation of dorsal lateral prefrontal cortex activation using real-time fMRI. PLoS One (2013) 1.00

Mobile FT mRNA contributes to the systemic florigen signalling in floral induction. Sci Rep (2011) 1.00

Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Neoplasia (2013) 1.00

MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1. PLoS One (2012) 0.99

Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells. J Med Virol (2010) 0.98

Akt1-mediated regulation of macrophage polarization in a murine model of Staphylococcus aureus pulmonary infection. J Infect Dis (2013) 0.98

Porcine Deltacoronavirus in Mainland China. Emerg Infect Dis (2015) 0.98

Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis. PLoS One (2013) 0.97

Unique residues crucial for optimal editing in yeast cytoplasmic Leucyl-tRNA synthetase are revealed by using a novel knockout yeast strain. J Biol Chem (2008) 0.97

Genetic diversity and haplotype structure of 24 Y-chromosomal STR in Chinese Hui ethnic group and its genetic relationships with other populations. Electrophoresis (2014) 0.97

Logical Analysis of Data (LAD) model for the early diagnosis of acute ischemic stroke. BMC Med Inform Decis Mak (2008) 0.96

Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J Lab Clin Med (2005) 0.96

miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3'UTR of CD46. Cancer Biol Ther (2010) 0.96

Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway. Oncol Rep (2012) 0.96

Transformation of human liver L-O2 cells mediated by stable HBx transfection. Acta Pharmacol Sin (2009) 0.95

Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. Carcinogenesis (2011) 0.95

A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells. Endocrinology (2008) 0.94

Wnt modulates MCL1 to control cell survival in triple negative breast cancer. BMC Cancer (2014) 0.93

Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers. Clin Cancer Res (2012) 0.92

G Protein binding sites on Calnuc (nucleobindin 1) and NUCB2 (nucleobindin 2) define a new class of G(alpha)i-regulatory motifs. J Biol Chem (2011) 0.91

Two new Co(II) and Ni(II) complexes with 3-(2-Pyridyl)pyrazole-based ligand: synthesis, crystal structures, and bioactivities. Chem Pharm Bull (Tokyo) (2007) 0.91

Three-dimensional networks in the 1:2 organic salts 2,2'-biimidazolium bis(3-carboxy-4-hydroxybenzenesulfonate) and 2,2'-bibenzimidazolium bis(3-carboxy-4-hydroxybenzenesulfonate) trihydrate. Acta Crystallogr C (2009) 0.91

Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP. Mol Cancer (2014) 0.90

Evaluation of acute toxicity of essential oil of garlic (Allium sativum) and its selected major constituent compounds against overwintering Cacopsylla chinensis (Hemiptera: Psyllidae). J Econ Entomol (2013) 0.90

HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF-κB signaling to protect breast cancer cells from complement attack. FEBS Lett (2012) 0.90

Reversible jump MCMC approach for peak identification for stroke SELDI mass spectrometry using mixture model. Bioinformatics (2008) 0.90

The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells. Cancer Lett (2013) 0.89

TF-Cluster: a pipeline for identifying functionally coordinated transcription factors via network decomposition of the shared coexpression connectivity matrix (SCCM). BMC Syst Biol (2011) 0.89

Synergistic apoptosis induction in leukemic cells by miR-15a/16-1 and arsenic trioxide. Biochem Biophys Res Commun (2010) 0.89

Matrine induces apoptosis of human multiple myeloma cells via activation of the mitochondrial pathway. Leuk Lymphoma (2010) 0.89

Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis. PLoS One (2013) 0.88

Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B. Vaccine (2008) 0.88

Virus-induced gene complementation reveals a transcription factor network in modulation of tomato fruit ripening. Sci Rep (2012) 0.88

Acaricidal activity of petroleum ether extracts from Eupatorium adenophorum against the ectoparasitic cattle mite, Chorioptes texanus. Parasitol Res (2014) 0.88

Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia. Proteomics (2010) 0.87

Progressive changes in hepatoma cells stably transfected with hepatitis B virus X gene. Intervirology (2008) 0.87

Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneity. PLoS One (2013) 0.87

Rh(I)-catalyzed carbonylative carbocyclization of tethered ene- and yne-cyclopropenes. Org Lett (2010) 0.87

High-performance and ultra-stable lithium-ion batteries based on MOF-derived ZnO@ZnO quantum dots/C core-shell nanorod arrays on a carbon cloth anode. Adv Mater (2015) 0.87

The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF. Carcinogenesis (2014) 0.86

Dinuclear metal(II) complexes of polybenzimidazole ligands as carriers for DNA delivery. Biomaterials (2009) 0.86

Involvement of RDR6 in short-range intercellular RNA silencing in Nicotiana benthamiana. Sci Rep (2012) 0.86

Tissue hypoxia correlates with intensity of interictal spikes. J Cereb Blood Flow Metab (2011) 0.85

The nuclear import of oncoprotein hepatitis B X-interacting protein depends on interacting with c-Fos and phosphorylation of both proteins in breast cancer cells. J Biol Chem (2013) 0.85

Measurement of liver volume and its clinical significance in cirrhotic portal hypertensive patients. World J Gastroenterol (1999) 0.85

The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells. Int J Cancer (2013) 0.85